Delivery Order SPE2DR25D2206-SPE2DR26F9SA2

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, with a ceiling value of $8,965.23 for supply of Revlimid 5 mg capsule 28-count units.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 5, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, for Revlimid 10 mg capsules (100-count), with a ceiling value of $205,107.35 under firm fixed-price terms. Place of performance is Conshohocken, PA. Ultimate completion date is March 4, 2026. The order was not set-aside and was issued competitively. The parent vehicle is an Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026,...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Revlimid 5 mg capsules (28-count) with a ceiling value of $12,329.15. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 30, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Revlimid 10 mg capsules (100-count units) with a ceiling value of $52,575.49. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, carries no set-aside designation and was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Revlimid 5 mg capsules (100 count) with a ceiling value of $120,863.94. This firm fixed price delivery order is scheduled for completion by January 12, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's established capability to...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count) with a ceiling value of $12,920.27. This is a firm fixed-price delivery order with an ultimate completion date of November 24, 2025, and was awarded on October 31, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....

The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $19,176.36 on January 14, 2026, for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by February 5, 2026, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite...

The Defense Logistics Agency awarded a $51,089.97 delivery order to AmerisourceBergen Drug Corp for Revlimid 10 mg capsules (28-count) on September 9, 2025, with performance completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Revlimid 2.5 mg capsules (28-count units) valued at $20,846.38 on January 7, 2026, with completion by January 29, 2026. This firm fixed-price contract represents a non-set-aside award issued under open competition. The order will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...

The Defense Logistics Agency awarded a delivery order valued at $7,233.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 25 mg capsules (quantity 21) on January 20, 2026, with a completion date of February 10, 2026. This firm fixed-price, non-set-aside contract was performed at the company's corporate office in Conshohocken, Pennsylvania. Revlimid is a specialized oncology medication used in the treatment of multiple myeloma and other hematologic malignancies, reflecting the Defense...